Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

Hikal Ltd

Pharmaceuticals & Biotechnology | Small Cap

Hikal Ltd Health Insights
Health Score : 7.13Health Score : 7.13

Hikal Ltd, operating in the Healthcare Services sector, demonstrates a mixed financial performance. The company shows strong solvency, growth, and profitability, indicating a solid foundation and effective management in these areas. However, liquidity and efficiency are areas of concern, suggesting potential challenges in meeting short-term obligations and optimizing asset utilization. The company's coverage ratios are reasonably good, reflecting its ability to meet its interest and dividend commitments. While the financial ratios are weak, the other strong areas provide a somewhat balanced view. Overall, Hikal Ltd appears to be a company with considerable strengths in long-term sustainability and earnings potential, but it needs to address its short-term financial management to ensure continued success.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
Hikal Ltd Health Insights
Health Score : 7.13Health Score : 7.13

Hikal Ltd, operating in the Healthcare Services sector, demonstrates a mixed financial performance. The company shows strong solvency, growth, and profitability, indicating a solid foundation and effective management in these areas. However, liquidity and efficiency are areas of concern, suggesting potential challenges in meeting short-term obligations and optimizing asset utilization. The company's coverage ratios are reasonably good, reflecting its ability to meet its interest and dividend commitments. While the financial ratios are weak, the other strong areas provide a somewhat balanced view. Overall, Hikal Ltd appears to be a company with considerable strengths in long-term sustainability and earnings potential, but it needs to address its short-term financial management to ensure continued success.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Neutral

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Neutral

P/E RATIO (TTM)

-50.28

Highly Undervalued

Industry Median

28.93

Highly Undervalued
Highly Undervalued

Small Cap Median

26.92

Highly Undervalued

P/E RATIO

-50.15

P/B RATIO

2.04

Undervalued

Industry Median

3.18

Undervalued
Undervalued

Small Cap Median

2.63

Undervalued

P/S RATIO

1.39

Undervalued

Industry Median

3.41

Undervalued
Undervalued

Small Cap Median

2.40

Undervalued

Others

Neutral

PEG RATIO

0.00

Neutral
Overvalued

EV/EBITDA RATIO

18.43

Overvalued

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹198.6 as on Jun 18, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 10.00

The company exhibits strong growth across all key metrics, including revenue, operating profit, EPS, assets, and net income. The company is expanding its operations and increasing its profitability. This suggests that the company is well-positioned for future success and has a competitive advantage in the market.

ExcellentRevenue Growth RateExcellent
ExcellentOperating Profit Growth RateExcellent
ExcellentEarnings Per Share (EPS) GrowthExcellent
ExcellentAsset Growth RateExcellent
ExcellentNet Income Growth RateExcellent
Growth RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue Growth Rate12.974.12-11.764.2-7.9
Operating Profit Growth Rate5.57-24.343.4922.85-32.93
Earnings Per Share (EPS) Growth20.56-51.15-11.3230.5-153.8
Asset Growth Rate15.687.774.281.69
Net Income Growth Rate20.3-51.25-10.2630-153.85
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 5.20

The company's financial ratios are not very good, indicating potential areas of concern. The Adjusted EPS, Cash EPS, Book Value Per Share, and Dividend Per Share are all quite low. However, the Capital Expenditures (CapEx) are very strong. This is because the weighted value is 0.

WeakAdjusted Earnings Per Share (Adjusted EPS)Weak
WeakCash Earnings Per Share (Cash EPS)Weak
WeakBook Value Per ShareWeak
WeakDividend Per Share (DPS)Weak
ExcellentCapital Expenditures (CapEx)Excellent
Financial RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Adjusted Earnings Per Share (Adjusted EPS)12.86.245.67.28
Cash Earnings Per Share (Cash EPS)20.4814.9615.04180
Book Value Per Share85.4490.7295.04101.04
Dividend Per Share (DPS)1.561.211.180.810.59
Capital Expenditures (CapEx)273302204136148
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 10.00

The company exhibits strong profitability across all key metrics, including Gross Profit Margin, ROCE, ROE, ROA, Operating Margin, and Net Margin. The company is generating healthy profits from its operations and effectively managing its expenses. This suggests that the company is well-positioned to sustain its profitability and deliver value to its shareholders.

ExcellentGross Profit MarginExcellent
ExcellentReturn on Capital Employed (ROCE)Excellent
ExcellentReturn on Equity (ROE)Excellent
ExcellentReturn on Assets (ROA)Excellent
ExcellentOperating MarginExcellent
ExcellentNet MarginExcellent
Profitability RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Profit Margin12.617.378.3510.433.27
Return on Capital Employed (ROCE)1588104
Return on Equity (ROE)14.986.885.897.21
Return on Assets (ROA)15.4110.8210.7412.97
Operating Margin17.5512.7514.9617.6312.84
Net Margin8.233.863.924.89-2.86
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 4.67

The company's efficiency ratios present a mixed picture. While Days Sales in Inventory and Receivable Days are very efficient, the other efficiency ratios are not. This is because the fixed asset, inventory and receivables turnover ratios are zero. If they were non-zero, the Days Sales in Inventory and Receivable Days would also be non-zero. The capital turnover ratio is also very low. This demonstrates that Hikal is not using its assets effectively to generate revenues.

PoorFixed Asset Turnover RatioPoor
PoorInventory Turnover RatioPoor
PoorReceivables Turnover RatioPoor
ExcellentDays Sales in Inventory RatioExcellent
ExcellentReceivable DaysExcellent
PoorCapital Turnover RatioPoor
Efficiency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Fixed Asset Turnover Ratio2.212.131.671.36
Inventory Turnover Ratio5.75.85.275.224.96
Receivables Turnover Ratio4.214.63.63.473.88
Days Sales in Inventory Ratio64.0462.9369.2669.9273.59
Receivable Days86.779.35101.39105.1994
Capital Turnover Ratio1.431.251.111.14
01.

Fixed Asset Turnover Ratio

02.

Inventory Turnover Ratio

03.

Receivables Turnover Ratio

04.

Days Sales in Inventory Ratio

05.

Receivable Days

06.

Capital Turnover Ratio

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 8.80

The company's coverage ratios are reasonably good, indicating a sufficient ability to meet its interest and dividend commitments. This suggests that the company is generating enough earnings to cover its interest expenses and dividend payments. While there is always room for improvement, the company's current coverage ratios provide a comfortable margin of safety.

GoodInterest Coverage RatioGood
ExcellentEquity Dividend Coverage RatioExcellent
Coverage RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Interest Coverage Ratio8.063.192.712.65-0.26
Equity Dividend Coverage Ratio8.335.264.769.09
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 10.00

The company exhibits strong solvency, indicating a solid long-term financial position. The debt and equity ratios suggest a balanced capital structure, with a healthy proportion of equity financing. This ensures the company has a strong financial foundation and is well-positioned to manage its debt obligations. This financial stability is a significant strength for the company.

ExcellentDebt RatioExcellent
ExcellentDebt to Equity RatioExcellent
ExcellentEquity RatioExcellent
ExcellentDebt To Asset RatioExcellent
Solvency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debt Ratio0.210.30.260.23
Debt to Equity Ratio0.270.430.350.3
Equity Ratio0.790.70.740.77
Debt To Asset Ratio0.130.210.170.15
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Equity Ratio

04.

Debt To Asset Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 2.80

The company's liquidity position needs attention. While the Operating Cash Flow Ratio is average, the other liquidity ratios indicate potential difficulties in meeting short-term obligations. While the company generates positive cash flow from its operations, it struggles to convert its current assets into cash to cover its immediate liabilities. This situation could pose risks in managing day-to-day operations and unexpected financial needs.

PoorCurrent RatioPoor
PoorQuick RatioPoor
PoorCash RatioPoor
AverageOperating Cash Flow RatioAverage
Liquidity RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Current Ratio1.21.341.141.15
Quick Ratio0.810.920.790.78
Cash Ratio0.060.080.020.02
Operating Cash Flow Ratio0.340.410.210.31
01.

Current Ratio

02.

Quick Ratio

03.

Cash Ratio

04.

Operating Cash Flow Ratio

Peer Comparison With 20 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1Amrutanjan Health Care Ltd8.2577.43Highly Overvalued31.0020.0321.00
2Supriya Lifescience Ltd7.4635.88Highly Overvalued294.0025.98209.00
3Aarti Pharmalabs Ltd7.4634.17Neutral369.0019.44175.00
4Innova Captab Ltd7.3637.88Overvalued243.0014.63141.00
5Hikal Ltd7.13-50.15Neutral220.00-3.95-49.00
6RPG Life Sciences Ltd7.1232.71Neutral147.0069.64115.00
7Morepen Laboratories Ltd7.1229.50Neutral126.001.2196.00
8Alembic Ltd7.067.59Undervalued90.004.85317.00
9SMS Pharmaceuticals Ltd5.9434.36Neutral171.009.35102.00
10Gufic BioSciences Ltd5.4955.88Neutral151.006.3064.00
11Dishman Carbogen Amcis Ltd5.3827.35Neutral566.00-2.4597.00
12IOL Chemicals & Pharmaceuticals Ltd5.3127.36Undervalued269.004.69138.00
13Indoco Remedies Ltd5.26-22.51Neutral142.00-0.61-99.00
14Aarti Drugs Ltd5.0717.33Undervalued309.0018.54195.00
15Orchid Pharma Ltd4.85248.95Neutral41.008.9121.00
16Sequent Scientific Ltd4.61291.78Overvalued162.000.6332.00
17Sun Pharma Advanced Research Company Ltd4.355.07Neutral1599.0047.831553.00
18Solara Active Pharma Sciences Ltd4.34-276.85Neutral187.00-1.50-7.00
19Zota Health Care Ltd3.97-59.69Neutral19.008.06-74.00
Management Assessment Summary
OrangeBalanced Management

The management of Hikal Ltd. demonstrates mixed performance. A consistently high promoter holding indicates strong confidence. Improving OPM points to enhanced operational efficiency. However, fluctuating sales growth and declining profit growth over the past three years raise concerns. A moderate level of debt adds to the challenges. While the management shows strengths in maintaining high promoter confidence and improving operational margins, addressing inconsistencies in revenue and profit growth is crucial for sustained performance.

Category Metric Value Assessment
PROS Promoter Holding 68.85% High, indicating strong confidence
Improving OPM 22% (Mar 2025) Shows better operational efficiency
CONS Fluctuating Sales Growth -11.79% (Mar 2024) Inconsistent revenue expansion
Declining Profit Growth -17% (3Y) Potential sustainability concerns
AverageFinancial Performance & GrowthAverage
WeakCapital Efficiency & ReturnsWeak
AverageFinancial Health & PrudenceAverage
GoodShareholding & Ownership StructureGood
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Shareholding & Ownership Structure

Risk Assessment Summary
OrangeBalanced Risk

The risk assessment for Hikal Ltd. indicates a moderate level of concern. Overall, the company presents a moderate risk profile requiring continued monitoring.

AverageOff-balance sheet exposure quantificationAverage
AverageContingent liability evaluationAverage
AverageRegulatory compliance cost trendsAverage
01.

Off-balance sheet exposure quantification

02.

Contingent liability evaluation

03.

Regulatory compliance cost trends

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 1 Technical Indicators From The 1 Hour Timeframe

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 1 Technical Indicators From The 2 Hours Timeframe

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 1 Technical Indicators From The 4 Hours Timeframe

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 1 Technical Indicators From The 1 Day Timeframe

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 1 Technical Indicators From The 1 Week Timeframe

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 1 Technical Indicators From The 1 Month Timeframe